Physician profile
John White
NPI 1427062066
$1,149.64
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $527 · 2020: $71.19 · 2022: $497 · 2023: $17.59 · 2024: $37.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $54.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $54.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $469.37 | 2022 | |
| Eisai INC. | $125.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $99.43 | 2019 | |
| Gilead Sciences, INC. | $95.94 | 2019-2024 | |
| Genzyme Corporation | $61.36 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $57.78 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $44.87 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $28.43 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.96 | 2019 | |
| Glaxosmithkline, LLC. | $22.42 | 2020 | |
| Circassia INC. | $18.66 | 2019 | |
| Genentech USA, INC. | $16.92 | 2019 | |
| Insmed, INC. | $15.01 | 2019 | |
| Merck Sharp & Dohme LLC | $14.55 | 2019 | |
| Mylan Specialty L.P. | $14.55 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $14.15 | 2019 | |
| Shire North American Group INC | $12.34 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.90 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.